Black Diamond Therapeutics BDTX
NASDAQ BDTX
$1.88 -0.20 (-9.62%)
At close: Oct 23, 2026 · 4:00 PM EDT

Black Diamond Therapeutics (BDTX) Interest & Investment Income (2019 - 2026)

Updated

Black Diamond Therapeutics (BDTX) recorded Interest & Investment Income of $922,000 in Q2 2026, down 17.5% from $1.12 million a year earlier and down 9.9% from the prior quarter.

Analysis

Black Diamond Therapeutics (BDTX) Interest & Investment Income (2019 - 2026) Analysis & Trends

On a TTM basis, Black Diamond Therapeutics' Interest & Investment Income came in at $4.29 million as of Jun 30, 2026, up 53.7% year-over-year; for FY2025, it was $4.06 million, up 86.1% from FY2024.

  • Annual Interest & Investment Income has a five-year compound annual growth rate of 0.1% (FY2020 to FY2025).
  • Across earlier years, Interest & Investment Income came in at $2.18 million in FY2024 (+13.4%), $1.92 million in FY2023 (-5.3%), $2.03 million in FY2022 (-41.4%) and $3.46 million in FY2021 (-14.3%).
  • The Q2 2026 figure is the lowest quarterly Interest & Investment Income since Q1 2025.
  • On a year-over-year basis, Interest & Investment Income rose in six of the last eight quarters, with growth averaging 64.5%.
  • Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 140.9% in Q2 2025, against a decline of 64.8% in Q1 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.02 million (Q1 2026), $1.18 million (Q4 2025) and $1.16 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 186.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 80.00 Mn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn -
10 Black Diamond Therapeutics 108.00 Mn -384.92 Mn - 922,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 922,000.00
Mar 31, 2026 1.02 Mn
Dec 31, 2025 1.18 Mn
Sep 30, 2025 1.16 Mn
Jun 30, 2025 1.12 Mn
Mar 31, 2025 595,000.00
Dec 31, 2024 565,000.00
Sep 30, 2024 516,000.00
Jun 30, 2024 464,000.00
Mar 31, 2024 637,000.00
Dec 31, 2023 324,000.00
Sep 30, 2023 439,000.00
Jun 30, 2023 539,000.00
Mar 31, 2023 622,000.00
Dec 31, 2022 677,000.00
Sep 30, 2022 562,000.00
Jun 30, 2022 386,000.00
Mar 31, 2022 406,000.00
Dec 31, 2021 588,000.00
Sep 30, 2021 776,000.00
API Access

Black Diamond Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=BDTX&period=max&api_key=YOUR_API_KEY